Parkwalk Advisors
Parkwalk Advisors Ltd is the UK's most active investor in university spinouts, managing c.£500 million in assets under management as the leading Enterprise Investment Scheme (EIS) fund manager focused on knowledge-intensive technology businesses spun out of leading UK universities including Oxford, Cambridge, Imperial College London, Bristol, Manchester, Leeds and Sheffield. Founded in 2009 and acquired by IP Group plc in 2017, Parkwalk has backed over 200 university spinouts and delivered more than £200 million cash returns to its EIS investors across 70+ exits. The firm is authorised and regulated by the UK Financial Conduct Authority under firm reference number 502237 (Companies House number 06925696). Its flagship Opportunities EIS Fund has raised the largest growth EIS fund in the UK market for five of the past six tax years. Registered address: 3 Pancras Square, London N1C 4AG.
Key facts
Recent exits
Coverage notes
2 funds tracked, 8 portfolio companies (1 active · 7 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Parkwalk Advisors has raised, with its portfolio companies. Hand-checked from public filings.
Parkwalk Knowledge Intensive EIS FundVC2021 · 5yr€83M1 active
Unrealized
1 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| AccelerComm | Deep Tech | UK | 2023 |
Parkwalk Opportunities EIS FundVC2009 · 17yr€585M0 active · 7 realized
Realized
7 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Cytora | Software | UK | 2015 | 2025 | Trade Sale | – | |
| Flusso | Deep Tech | UK | 2020 | 2022 | Trade Sale | – | |
| Horizon Discovery | Biotech | UK | 2013 | 2017 | Secondary | – | – |
| Jukedeck | AI/ML | UK | 2014 | 2019 | Trade Sale | – | |
| PetMedix | Biotech | UK | 2019 | 2023 | Trade Sale | – | |
| VocalIQ | AI/ML | UK | 2014 | 2015 | Trade Sale | – | |
| YASA | Mobility | UK | 2012 | 2021 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Parkwalk Advisors
Parkwalk Advisors is the UK's most active university spinout investor with approximately £450 million of assets under management as of December 2024 (£483.4 million deployed across 200 companies by June 2025), headquartered in London at 3 Pancras Square, King's Cross. The firm was founded in 2009 as a university spinout EIS specialist before being acquired by IP Group plc in 2017, now operating as a wholly-owned subsidiary of IP Group plc (LSE: IPO). Parkwalk completed 41 deals in 2024 (54 with IP Group).
Investment thesis
Parkwalk Advisors deploys capital through 15 plus EIS funds across two main families: the Opportunities EIS Fund (annual vintages since 2011) and the Knowledge Intensive EIS Fund (Funds I-V since 2021). The platform provides EIS and Knowledge Intensive EIS fund management with early-stage to scale-up co-investment alongside parent IP Group in university spinouts. Sector focus spans deep tech (AI, quantum, hardware, advanced materials), healthtech and digital health and life sciences and cleantech (agtech, future mobility, energy). Geographic deployment is UK-only with focus on spinouts from Oxford, Cambridge, Imperial, UCL, Manchester, Bristol, Southampton and Leeds.
Recent activity
Recent realised exits include insurtech and AI (2025) and quantum computing (2025, co-investment with Oxford Capital in Oxford Ionics). Recent acquisitions include quantum computing follow-on (2026), hardware and metrology (2026) and hardware seed (2026). The platform continues active deployment across the UK university spinout franchise. Detailed buyer names and multiple data available on Pro at €29/month.
Investment team
Senior partners. Hand-checked from public filings and the firm's own site.
Similar firms
Other private equity firms tracked on GP Intel.